Allergan Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (61)

Latest Posts

About This Stock More About This Stock
Pharma Stock Roundup: Mixed Q1 For MRK, PFE, FDA Nod For Kymriah's 2nd Indication
Article By: Zacks Investment Research
Friday, May 4, 2018 8:15 PM EDT
First-quarter results of pharma bigwigs like Pfizer, Merck and Allergan stole the limelight this week. Other than that, Novartis gained FDA approval for the second indication of its CAR-T therapy, Kymriah.
In this article: AGN, JNJ, MRK, NVS, PFE, UTHR, ABBV
Allergan Beats Q1 Earnings, Stock Up
Article By: Zacks Investment Research
Monday, April 30, 2018 12:09 PM EDT
Allergan’s first-quarter earnings of $3.74 per share were above our consensus estimate of $3.36 per share.
In this article: AGN
Should You Buy Allergan Plc When Prices Drop?
Article By: Matthew Hogan
Wednesday, April 4, 2018 4:37 PM EDT
Allergan plc investors have enjoyed seeing the stock price increase by 16.9% over the last month.
In this article: AGN
Allergan Slides After Mylan, Revance Report Deal For Botox Biosimilar
Article By: The Fly
Thursday, March 1, 2018 12:25 PM EDT
Shares of Allergan are under pressure this morning after Mylan and Revance Therapeutics announced an agreement for the development and commercialization of a proposed biosimilar to Botox.
In this article: AGN Also: MYL, RVNC
Allergan: Europe Halts Esmya Prescriptions Amid Liver Risk Probe
Article By: Shock Exchange
Friday, February 23, 2018 10:34 AM EDT
The European Medicines Agency advised that no new patients take Esmya due to potential links to liver injury. The decision could stymie AGN's attempt to seek FDA approval for Esmya in the U.S.
In this article: AGN Also: GEDRY, GEDSF


Latest Tweets for $AGN

No tweets yet!


Patent Losses Could Sink Allergan
Dean Gilmore 2/5/2018 2:37:30 PM

Look at where $AGN was a year ago. It has lost a chunk of it's value already. This news won't help.

Patent Losses Could Sink Allergan
Alpha Stockman 2/5/2018 2:26:42 PM

These hits all hurt #Allergan's bottom line but aren't it's cash cows like #Botox which still does very well for the company and will only only generate even more revenue over time. $AGN

Patent Losses Could Sink Allergan
Ayelet Wolf 2/5/2018 2:22:51 PM

This news sounds catastrophic to me. Why isn't #Allergan tanking? $AGN

Valeant Edges Up 15% After Announcing That It Will Acquire Salix
Terry Caruso 2/24/2015 8:20:44 PM

You said the company tried to acquire Allergan but the deal fell through because Valeant didn't like it's large R&D program. If true, why did it try to acquire $AGN in the first place?

1 to 4 of 4 comments